RPG Life Sciences fixes record date for dividend

1 min read     Updated on 02 Jul 2026, 10:02 PM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

RPG Life Sciences announced its Nineteenth Annual General Meeting for July 23, 2026, via video conferencing, with a record date of July 16, 2026, for dividend entitlement. The company reported an 8.3% revenue growth to ₹707.52 crores for FY26, driven by a 13.8% rise in Domestic Formulations, while International Formulations saw a 6.7% decline.

powered bylight_fuzz_icon
44466153

*this image is generated using AI for illustrative purposes only.

RPG Life Sciences Limited has announced the schedule for its Nineteenth Annual General Meeting (AGM), scheduled for Thursday, July 23, 2026, at 3.00 p.m. IST via Video Conferencing. The company has fixed Thursday, July 16, 2026, as the record date to determine the eligibility of members entitled to receive the dividend, subject to shareholder approval. The remote e-voting facility will be available from Monday, July 20, 2026, at 09:00 a.m. to Wednesday, July 22, 2026, at 05:00 p.m.

Financial Performance

The company reported total income of ₹733.06 crores for the year ended March 31, 2026, compared to ₹666.11 crores in the previous year. Revenue from operations stood at ₹707.52 crores, registering a growth of 8.3%. Profit for the year after tax was ₹115.17 crores, while EBITDA margins were maintained at 24.4%. The balance sheet remained strong with cash reserves of approximately ₹275 crores.

Metric FY 2025-26 FY 2024-25
Total Income (₹ crores) 733.06 666.11
Profit before tax (₹ crores) 154.20 232.88
Profit for the year (₹ crores) 115.17 183.24
Basic EPS (₹) 69.64 110.80

Segment and Operational Highlights

Domestic Formulations revenue grew 13.8% year-on-year to ₹483.5 crores, outperforming the Indian Pharmaceutical Market growth of 8.6%. International Formulations reported a de-growth of 6.7% to ₹123.43 crores, while API sales increased 5.3% to ₹95.06 crores. The API plant is now fully operational following restoration post the fire incident. The Board has recommended a final dividend of ₹24 per equity share (300%) for FY 2025-26.

Historical Stock Returns for RPG Life Sciences

1 Day5 Days1 Month6 Months1 Year5 Years
-3.41%-2.54%+24.33%+30.97%+12.44%+528.86%

What strategies will the company implement to reverse the de-growth in the International Formulations segment?

How does the company plan to utilize its strong cash reserves of ₹275 crores for future expansion or acquisitions?

Will the operational restoration of the API plant lead to increased capacity or new product launches in the coming year?

RPG Life Sciences fixes record date July 9 for ₹24 dividend

1 min read     Updated on 24 Jun 2026, 01:10 AM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

RPG Life Sciences Limited has fixed July 9, 2026, as the record date for a final dividend of ₹24 per share, subject to shareholder approval at the AGM on July 23, 2026. The meeting will be held via video conferencing.

powered bylight_fuzz_icon
43194945

*this image is generated using AI for illustrative purposes only.

RPG Life Sciences Limited has fixed Thursday, July 9, 2026, as the record date to determine shareholder eligibility for a final dividend of ₹24 per share for the financial year ended March 31, 2026. The dividend, recommended by the Board at its meeting on April 29, 2026, is subject to approval by shareholders at the Nineteenth Annual General Meeting (AGM) scheduled for Thursday, July 23, 2026. The payment will be made within 30 days of the AGM to members whose names appear in the Register of Members or the depositories' records on the record date.

The company communicated this decision to the National Stock Exchange of India Limited and BSE Limited pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The AGM will be conducted through Video Conferencing (VC) or Other Audio-Visual Means (OAVM) at 3.00 p.m. (IST).

Symbol/Script code Type of security Record date Purpose
NSE: RPGLIFE
BSE: 532983
Equity Thursday, July 9, 2026 Payment of final dividend of ₹24 (300%) per Equity share of ₹8 each for FY26, subject to approval at the AGM on July 23, 2026.

Rajesh Shirambekar, Head – Legal & Company Secretary, signed the regulatory filing confirming the schedule. The company has requested the exchanges to take the information on record. The Notice of AGM, containing further relevant details, will be issued in due course.

Historical Stock Returns for RPG Life Sciences

1 Day5 Days1 Month6 Months1 Year5 Years
-3.41%-2.54%+24.33%+30.97%+12.44%+528.86%

What factors might influence shareholder approval of the ₹24 per share dividend at the upcoming AGM?

How will this significant dividend payout impact RPG Life Sciences' capital allocation strategy for FY27?

Could this high dividend yield signal a shift in the company's policy towards returning excess cash to investors?

More News on RPG Life Sciences

1 Year Returns:+12.44%